Skip to main content

Innovatus Life Sciences Acquisition Corp. (ILAC)

Innovatus Life Sciences Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Market Cap224.60M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out22.46M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About ILAC

Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to initially focus our search on identifying a prospective target business in the life sciences sector. Our sponsor is an affiliate of Innovatus Capital Partners, LLC, a boutique private equity firm with 27 professionals focused on creating value in special situations, growth equity, emergin...

IndustryBlank Checks / SPAC
IPO DatePending
CEODavid Schiff
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolILAC
Full Company Profile

News

Innovatus Life Sciences Acquisition IPO Registration Document (S-1)

Innovatus Life Sciences Acquisition Corp. has filed to go public with an IPO on the NASDAQ.

5 months ago - SEC